XBiotech: Well-Funded, Working On The Next Bermekimab, And Undervalued

XBiotech develops True Human™ (naturally occurring) monoclonal antibodies that neutralise inflammation-causing interleukin-1 alpha, and may be useful in treating infectious diseases – including …
Bron: XBiotech: Well-Funded, Working On The Next Bermekimab, And Undervalued